A recent Freakonomics report examines the scientific and systemic barriers, including an overreliance on outdated biological hypotheses, that have historically slowed progress in Alzheimer's disease research. The segment highlights that overcoming these challenges will require innovative biotechnological approaches, earlier clinical interventions, and a fundamental shift in how the disease is studied and funded.